MAHESHWARAPPA REVAKKA SUNIL KUMAR
DIN: 09045676
Profile Summary
MAHESHWARAPPA REVAKKA SUNIL KUMAR is registered with the Ministry of Corporate Affairs as a director in Indian companies. Currently, he/she serves as a director in 10 companies.
Director Stats
10
Companies
10
Active
0
Resigned
2021-03-01
First Appointment
Companies
Company | Designation | Appointment Date | Exit Date |
---|---|---|---|
PRERANA HOSPITAL LIMITED | Additional Director | 25 Oct 2024 | Active |
ASTER DM HEALTHCARE LIMITED | CFO | 25 May 2023 | Active |
ALFAONE RETAIL PHARMACIES PRIVATE LIMITED | 30 Sep 2022 | Active | |
DR. RAMESH CARDIAC AND MULTISPECIALITY HOSPITAL PRIVATE LIMITED | Director | 30 Sep 2022 | Active |
ALFAONE MEDICALS PRIVATE LIMITED | 08 Nov 2021 | Active | |
SRI SAINATHA MULTISPECIALITY HOSPITALS PRIVATE LIMITED | Director | 08 Nov 2021 | Active |
SANGHAMITRA HOSPITALS PRIVATE LIMITED | Director | 27 Sep 2021 | Active |
ASTER CLINICAL LAB LLP | Designated Partner | 03 Sep 2021 | Active |
MINDRIOT RESEARCH AND INNOVATION FOUNDATION | 10 Mar 2021 | Active | |
MINDRIOT RESEARCH AND DEVELOPMENT PRIVATE LIMITED | 01 Mar 2021 | Active |
FAQs
What is the DIN of MAHESHWARAPPA REVAKKA SUNIL KUMAR?
The Director Identification Number (DIN) of MAHESHWARAPPA REVAKKA SUNIL KUMAR is 09045676.
Which companies is MAHESHWARAPPA REVAKKA SUNIL KUMAR currently associated with?
MAHESHWARAPPA REVAKKA SUNIL KUMAR is currently a director in the following companies: PRERANA HOSPITAL LIMITED, ASTER DM HEALTHCARE LIMITED, ALFAONE RETAIL PHARMACIES PRIVATE LIMITED, DR. RAMESH CARDIAC AND MULTISPECIALITY HOSPITAL PRIVATE LIMITED, ALFAONE MEDICALS PRIVATE LIMITED, SRI SAINATHA MULTISPECIALITY HOSPITALS PRIVATE LIMITED, SANGHAMITRA HOSPITALS PRIVATE LIMITED, ASTER CLINICAL LAB LLP, MINDRIOT RESEARCH AND INNOVATION FOUNDATION, MINDRIOT RESEARCH AND DEVELOPMENT PRIVATE LIMITED.
When was the first directorship of MAHESHWARAPPA REVAKKA SUNIL KUMAR?
Based on available data, the earliest recorded directorship for MAHESHWARAPPA REVAKKA SUNIL KUMAR was in March 2021.